Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | CGEM | EYPT | ||
| Company | Inhibrx Biosciences Inc | Cullinan Therapeutics Inc | Eyepoint Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 87.06 | 20.02 | 4.06 | ||
| High | 92.49 | 21.22 | 4.73 | ||
| Low | 85.06 | 19.90 | 3.95 | ||
| Last | 91.96 | 20.76 | 4.50 | ||
| Change | +3.59 | +0.42 | -10.25 | ||
| Percent Change | +4.06% | +2.06% | -69.49% | ||
| Volume | 79,389 | 397,726 | 40,675,673 | ||
| 20-Day Average Volume | 200,313 | 596,185 | 3,663,956 | ||
| Previous | 88.37 | 20.34 | 14.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 86.68 | 18.07 | 12.36 | ||
| 20-Day Raw Stochastic | 60.03% | 89.42% | 5.39% | ||
| 20-Day Relative Strength | 51.05 | 67.05 | 27.91 | ||
| Weighted Alpha | +62.85 | +152.99 | -12.36 | ||
| Today's Opinion | 40% Buy | 100% Buy | 96% Sell | ||
| Yesterday's Opinion | 24% Buy | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 24% Buy | 88% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.61% since 08/10/26 | +13.07% since 08/10/26 | -64.96% since 08/10/26 | ||
| Low | 85.06 on 08/17/26 | 18.24 on 08/11/26 | 4.00 on 08/17/26 | ||
| High | 101.00 on 08/13/26 | 21.22 on 08/17/26 | 14.76 on 08/14/26 | ||
| 1-Month | |||||
| %Chg | +4.83% since 07/17/26 | +16.85% since 07/17/26 | -65.56% since 07/17/26 | ||
| Low | 77.50 on 07/29/26 | 16.02 on 08/03/26 | 4.00 on 08/17/26 | ||
| High | 101.00 on 08/13/26 | 21.22 on 08/17/26 | 14.76 on 08/14/26 | ||
| 3-Month | |||||
| %Chg | -15.68% since 05/15/26 | +31.40% since 05/15/26 | -62.91% since 05/15/26 | ||
| Low | 77.50 on 07/29/26 | 11.68 on 06/10/26 | 4.00 on 08/17/26 | ||
| High | 113.95 on 05/20/26 | 21.22 on 08/17/26 | 15.92 on 07/01/26 | ||
| 6-Month | |||||
| %Chg | +16.30% since 02/17/26 | +69.57% since 02/17/26 | -69.28% since 02/17/26 | ||
| Low | 57.30 on 03/27/26 | 11.68 on 06/10/26 | 4.00 on 08/17/26 | ||
| High | 155.29 on 04/22/26 | 21.22 on 08/17/26 | 18.87 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,296,475 | 1,308,981 | 1,271,627 | ||
| Shares Outstanding, K | 14,671 | 64,355 | 86,212 | ||
| Annual Sales, $M | 1,300,000 | 0 | 31,370,000 | ||
| Annual Net Income, $M | -140,060,000 | -219,880,000 | -231,960,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 510,000 | ||
| Last Qtr Income, $M | -33,440,000 | -53,700,000 | -94,470,000 | ||
| 60-Month Beta | 3.51 | 0.01 | 1.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.15 on 05/14/26 | -0.81 on 08/06/26 | -1.09 on 08/05/26 | ||
| Latest Earnings Date | 11/13/26 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||